Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8]

Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8
Study of Epratuzumab in Systemic Lupus Erythematosus [clinicaltrials:NCT00111306]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Patient response variable (complete response, partial response, non-response) evaluated at 24 weeks. [clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8
Bio2RDF identifier
1f2a9f00d84e74bfd6a224ffd2f53ee8
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8
measure [clinicaltrials_vocabulary:measure]
Patient response variable (com ...... sponse) evaluated at 24 weeks.
identifier
clinicaltrials_resource:1f2a9f00d84e74bfd6a224ffd2f53ee8
title
Patient response variable (com ...... sponse) evaluated at 24 weeks.
@en
inDataset
type
label
Patient response variable (com ...... a9f00d84e74bfd6a224ffd2f53ee8]
@en